Related Experiment Video
Updated: May 21, 2025
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Application of RNA sequencing in urologic malignancies: Advances and challenges
Khaleel I Al-Obaidy1, Liang Cheng2
1McLaren Pathology Group, McLaren Health Care, Flint, MI; Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI.
Abstract:
RNA sequencing became a key tool in identifying the differences between cells and their functions, aiding in the recognition of the functional elements disrupted during the disease process. In urologic malignancies, many studies aiming to provide comprehensive molecular classifications through the assessment of RNA expression or fusion analysis have been published. The distinctive presence of these molecular alterations related to cancer development, growth, and survival and the discoveries of these breakthrough studies provide insight into the development of personalized management and aid in the identification of new therapeutic targets.
Insights
RNA sequencing reveals cellular differences and disruptions in urologic malignancies. These findings enhance personalized cancer management and identify novel therapeutic targets for improved patient outcomes.
Area of Science:
- Genomics and Molecular Biology
- Oncology
- Urologic Diseases
Background:
- RNA sequencing is crucial for understanding cellular functions and identifying disease-related molecular alterations.
- Numerous studies have explored RNA expression and fusion analysis in urologic malignancies for molecular classification.
Purpose of the Study:
- To highlight the significance of RNA sequencing in characterizing urologic cancers.
- To emphasize how molecular insights from RNA studies inform personalized medicine and therapeutic target discovery.
Main Methods:
- Assessment of RNA expression profiles.
- Analysis of RNA fusion events.
Main Results:
- Identification of distinct molecular alterations driving cancer development, growth, and survival in urologic malignancies.
- Comprehensive molecular classifications based on RNA data.
Conclusions:
- RNA sequencing provides critical insights into the molecular landscape of urologic cancers.
- These discoveries pave the way for personalized treatment strategies and the development of new therapies.
Related Concept Videos
03:21RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
03:00Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....